Market Analysis and Insights:- Global Autism Drug Market
Global Autism Drug Market By Type (Asperger Syndrome, Pervasive Developmental Disorder and Autistic Disorder), Mechanism of Action (Antipsychotics, Anticonvulsants, Antidepressants, Stimulants and Others), Drugs Type (Risperidone, Fluoxetine, Clomipramine, Methylphenidate, Phenytoin and Others), Therapy Type (Behavioral Therapy, Occupational Therapy, Physical Therapy, Speech Therapy and Others), Route of Administration (Oral, Intravenous and Others), Distribution Channel (Online Pharmacy, Direct Tenders (Retailers and Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Market Analysis: Global Autism Drug Market
Global autism drug market is expected to grow at a steady CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the rising awareness about the disorder, increasing prevalence in the market, development in the healthcare expenditure and the government support for the research & development for new and better treatment have fueled the market growth.
Get More Insight About the Global Autism Drug Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=glo...

Market Definition: Global Autism Drug Market
Autism is a CNS associated disorder characterized by number of disabilities such as difficulty in speech, challenges with behavior of the individual and lack of social skills like verbal and nonverbal communication. The intensity can be mild, severe or somewhere in between and it is different with every individual. Diagnosis of autism can be done from a very young age with kids of age 2-3 year old. The cause of this disorder is yet unknown, but constant research and development is being carried on for the complete information of the disease.
According to the report of Centers for Disease Control and Prevention (CDC) in the year 2018, approximately 1 in 59 children is diagnosed with an autism spectrum disorder (ASD), 1 in 37 boys and 1 in 151 girls. The chances of diagnosis in boys are four times more than girls.
Market Drivers:
• Rising prevalence of autism and pervasive developmental disorder (PDD) is driving the growth of this market
• Rising awareness about autism among the patient population also acts as a market driver
• Increased research and development initiatives and expenditure, is also expected to drive the market growth
• Approvals of various off-label treatment therapies by the Food and Drug Association (FDA) can also enhance the market growth
Market Restraints:
• Stringent regulations and approval procedure by the authorities for the treatment, is also expected to act as a restraint for this market growth
• Inability of penetration in developing areas and awareness in those regions is also expected to restricts the market growth
• Powerless pipeline of drugs for autism disorder also hinders the market growth
Know More About this Report @ https://www.databridgemarketresearch.com/reports/global-autism-drug...
Segmentation: Global Autism Drug Market
By Type
• Asperger Syndrome
• Pervasive Developmental Disorder
• Autistic Disorder
By Mechanism of Action
• Antipsychotics
• Anticonvulsants
• Antidepressants
• Stimulants
• Others
Drugs Type
• Risperidone
• Fluoxetine
• Clomipramine
• Methylphenidate
• Phenytoin
• Others
Therapy Type
• Behavioral Therapy
• Occupational Therapy
• Physical Therapy
• Speech Therapy
• Others
By Route of Administration
• Oral
• Intravenous
• Others
By Distribution Channel
• Online Pharmacy
• Direct Tenders
• Retailers
• Others
By End-Users
• Hospitals
• Homecare
• Specialty Clinics
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o Italy
o U.K.
o France
o Spain
o Netherlands
o Belgium
o Switzerland
o Turkey
o Russia
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o South Korea
o Australia
o Singapore
o Malaysia
o Thailand
o Indonesia
o Philippines
o Rest of Asia Pacific
• South America
o Brazil
o Rest of South America
• Middle East & Africa
o South Africa
o Rest of Middle East & Africa
Key Developments in the Market:
• In February 2019, Cognoa received breakthrough device designation from FDA for its lead product, the first digital diagnostic and digital therapeutic devices for autism. This device designed to support prior identification and treatment of pediatric behavioral health condition associated with autism
• In January 2018, F. Hoffmann-La Roche Ltd received breakthrough therapy designation from FDA for Balovaptan to treat autism spectrum disorder (ASD), This will accelerate the development and approval of the drug. Balovaptan has a potential to improve “core social interaction and communication” in those with autism
Competitive Analysis:
Global autism drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of autism drug market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Players:
The key market players in the global autism drug market are Bristol-Myers Squibb Company, ALLERGAN, AbbVie Inc, Johnson & Johnson Services, Takeda Pharmaceutical Company Limited, Merck & Co., Inc, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Abbott, Pfizer Inc, Novartis AG, Saniona, Intra-Cellular Therapies, Inc, Curemark, LLC, Coronis Neurosciences Ltd., Otsuka Holdings Co., Ltd, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd., Medtronic and others.
Research Methodology: Global Autism Drug Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-autism-dr...
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Reasons to Purchase this Report
• Current and future of global autism drug market outlook in the developed and emerging markets.
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
• The latest developments, market shares, and strategies that are employed by the major market players.
Access Full report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/gl...
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]